AzTrials
AzTrials

Adolescence Idiopathic ScoliosisNCT07359781

Validity and Reliability of the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2) in Adolescents With Idiopathic Scoliosis

An observational study of Adolescence Idiopathic Scoliosis, run by Nigde Omer Halisdemir University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Adolescent idiopathic scoliosis (AIS) is a spinal condition that develops during adolescence and often requires long-term conservative treatment, including scoliosis-specific therapeutic exercises. The success of exercise-based treatment largely depends on adolescents' motivation to start and continue exercising. Read more about this study

Who is it for?
Ages 10 to 19 years
Conditions the study is for
Adolescence Idiopathic Scoliosis
What is being tested?
Questionnaire Assessment
How many people
95 participants
Where
1 siteTurkey (Türkiye)
Study dates
Jan 2026to Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 19 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: The study population consists of adolescents aged 10 to 19 years who have been diagnosed with adolescent idiopathic scoliosis and are currently receiving scoliosis-specific exercise-based physiotherapy.

Who may be able to join

  • Aged between 10 and 19 years
  • Diagnosed with adolescent idiopathic scoliosis
  • Receiving scoliosis-specific therapeutic exercise treatment for at least 2 months
  • Able to read and write in Turkish
  • Volunteered to participate in the study and provided informed consent

Who cannot join

  • Presence of congenital or neuromuscular scoliosis
  • Presence of systemic disease
  • Presence of syndromic conditions such as Marfan syndrome or Ehlers-Danlos syndrome

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Nigde Omer Halisdemir University

    Niğde, Niğde Province

    05447121998

Other trials in Turkey (Türkiye)

About this study

Official title: Assessment of Exercise Motivation in Adolescent Idiopathic Scoliosis: Validity and Reliability Study of the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2)

Adolescent idiopathic scoliosis (AIS) is a spinal condition that develops during adolescence and often requires long-term conservative treatment, including scoliosis-specific therapeutic exercises. The success of exercise-based treatment largely depends on adolescents' motivation to start and continue exercising. However, exercise motivation has not been adequately evaluated in adolescents with idiopathic scoliosis using validated tools specific to this population.

The Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2) is a widely used questionnaire based on Self-Determination Theory that assesses different types of motivation toward exercise. Although the Turkish version of the BREQ-2 exists, its validity and reliability have not yet been examined in adolescents with idiopathic scoliosis.

The purpose of this study is to evaluate the validity and reliability of the Turkish version of the BREQ-2 in adolescents diagnosed with idiopathic scoliosis. Adolescents aged 10-19 years who have been participating in scoliosis-specific therapeutic exercise programs for at least two months will be invited to complete online questionnaires. The results of this study will help determine whether the BREQ-2 is an appropriate tool for assessing exercise motivation in this population and may support the development of individualized motivational strategies in scoliosis rehabilitation.

Read the detailed description

Adolescent idiopathic scoliosis (AIS) is a three-dimensional deformity of the spine that emerges during growth and often requires prolonged conservative management. Physiotherapeutic scoliosis-specific exercises (PSSE) are recommended in international guidelines and have demonstrated effectiveness in controlling curve progression and improving functional outcomes. However, adherence to exercise programs remains a major challenge, particularly during adolescence, where motivation plays a critical role in sustaining health-related behaviors.

Exercise motivation is commonly conceptualized within the framework of Self-Determination Theory as a continuum ranging from amotivation to intrinsic motivation. The Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2) is a theory-based, multidimensional instrument designed to assess motivational regulation underlying exercise behavior. While the BREQ-2 has demonstrated strong psychometric properties across different populations, its validity and reliability have not been established in adolescents with idiopathic scoliosis.

This study is designed as a methodological, cross-sectional validation study aiming to evaluate the validity, reliability, and applicability of the Turkish version of the BREQ-2 in adolescents with idiopathic scoliosis. Participants aged 10-19 years who have been receiving scoliosis-specific therapeutic exercise treatment for at least two months will be recruited. Data will be collected using online questionnaires, including the BREQ-2, the motivation subscale of the Questionnaire on Physiotherapeutic Scoliosis-Specific Exercises (QPSSE), and the Exercise Motivations Inventory-2 (EMI-2).

Internal consistency of the BREQ-2 will be assessed using Cronbach's alpha coefficients. Test-retest reliability will be evaluated using the intraclass correlation coefficient (ICC) with a two-week interval between administrations. Criterion-related validity will be examined by analyzing correlations between BREQ-2 scores and scores obtained from the QPSSE motivation subscale and the EMI-2. Statistical analyses will be performed using appropriate correlation methods based on data distribution.

The findings of this study are expected to provide evidence regarding the psychometric adequacy of the BREQ-2 for assessing exercise motivation in adolescents with idiopathic scoliosis. Establishing a valid and reliable motivation assessment tool may contribute to improved evaluation of treatment adherence and support the development of individualized motivational approaches in scoliosis rehabilitation.

Being tested
Questionnaire Assessment
Keywords
Adolescent idiopathic scoliosis, Exercise motivation, Behavioral regulation, Validity and reliability, Self-determination theory

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaire AssessmentOther

    No intervention is administered. Participants complete self-reported questionnaires (BREQ-2, QPSSE motivation subscale, and EMI-2) for the assessment of exercise motivation.

Study groups in NCT07359781
Study groupRoleWhat they receive
Adolescents With Idiopathic ScoliosisAdolescents aged 10-19 years diagnosed with adolescent idiopathic scoliosis who have been receiving scoliosis-specific exercise therapy for at least two months and who voluntarily participate in the study.
Receives: Other: Questionnaire Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Validity and Reliability of the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2)

    The primary outcome is the psychometric evaluation of the Turkish version of the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2) in adolescents with idiopathic scoliosis, including internal consistency, test-retest reliability, and criterion-related validity.

    Measured: Baseline assessment; test-retest reliability assessed over a 2-week interval

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2026
  2. Study startJan 2026 (estimated)
  3. Primary completionSep 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
95 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07359781
Sponsor's protocol ID
OHU-HHK-QV-2026-01
Status last verified
Jan 2026
First submitted
13 Jan 2026
Last updated
28 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Individual participant data (IPD) sharing has not yet been determined. Decisions regarding data sharing will be made following completion of the study, in accordance with institutional policies, ethical approval conditions, and data protection regulations.

Questions about this trial

What is this clinical trial studying?

An observational study of Adolescence Idiopathic Scoliosis, run by Nigde Omer Halisdemir University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hafize Hilal KARGIN (+905447121998, hafizehilalkargin@ohu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Validity and Reliability of the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2) (time frame: Baseline assessment; test-retest reliability assessed over a 2-week interval). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in